Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent in routine PCI: three-year clinical outcomes from the AIDA trial
September 20, 2019 | 10.4244/EIJ-D-19-00325
Showing 1-11 of 11 articles
Coronary interventions
Final results of the Randomised Evaluation of short-term DUal antiplatelet therapy in patients with acute Coronary syndromE treated with a new generation stent (REDUCE) trial August 20, 2019 | 10.4244/EIJ-D-19-00539
Coronary interventions
Bioresorbable vascular scaffold versus Xience metallic stents: outcomes in the AIDA trial stratified by SYNTAX score May 7, 2019 | 10.4244/EIJ-D-18-00884
Coronary interventions
Safety and performance of a resorbable magnesium scaffold under real-world conditions: 12-month outcomes of the first 400 patients enrolled in the BIOSOLVE-IV registry January 22, 2019 | 10.4244/EIJ-D-18-01058
Three-year clinical outcome in the Primary Stenting of Totally Occluded Native Coronary Arteries III (PRISON III) trial: a randomised comparison between sirolimus-eluting stent implantation and zotarolimus-eluting stent implantation for the treatment of total coronary occlusions
March 20, 2015 | 10.4244/EIJY14M08_07
